Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.
 
CDD — Computational Drug Development
ID
842512
Dates
13 dec 2016 - 15 dec 2016
Lieu
Boston, MA, États-Unis
Résumé
Computational Drug Development 2016 will bridge the gap between the application of computational tools for small molecule and biologic drug development. This meeting will bring together leading computational scientists from pharma, biotech, academia and software companies to evolve new solutions to focus the growing computational power on the richly accessible information generated in discovery and development.
Contact
Charlotte Harrison;     Email.: info@hansonwade.com
Sujets apparentés
2.
 
Powerful Closed-loop CAPA - Meeting FDA Expectations
ID
852597
Date de début
14 dec 2016
Lieu
Palo Alto - online, États-Unis
Résumé
This 90-minute webinar will show how you can implement a closed-loop CAPA system that meets CGMP requirements and U.S. FDA expectations. You will learn simple, but powerful, tools and methods that you can use regularly and systematically to define and resolve root causes, not just symptoms.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA Compliant CAPA, FDA Expectations for Root Cause Analysis, Failure Investigation Methodology, GMP Audit, Non-conformance, OOS resolution, Complaint Handling, Adverse Event Reporting and Resolution
3.
 
Understanding and Remediating Corrosion Problems during Parenterals Manufacturing
ID
852595
Date de début
14 dec 2016
Lieu
Palo Alto - online, États-Unis
Résumé
In this two-hour webinar you will learn how to recognize problems related to corrosion, how to diagnose their specific causes, and how to remediate them. This webinar surveys the range of corrosion-mediated failure modes of parenteral solution manufacture. The roles of physical factors such as temperature, humidity, oxygen as well as formulation variables such as chloride level, pH, and inorganic metals will be discussed in this session.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
ICH Q3D, Elemental Impurities Regulations, Corrosion, elemental impurity guidelines, laboratory scale simulations, metallurgical tests
4.
 
Effective Deviation Investigators Under GMP
ID
852649
Date de début
15 dec 2016
Lieu
Palo Alto - online, États-Unis
Résumé
This 120 minute training course will help attendees understand the fundamental steps of a deviation investigation with focus on using facts and objective evidence to arrive at root cause and CAPA. Learn how to identify and avoid potential pitfalls during deviation investigations.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Deviation, CAPA, OOS, deviation investigations, GMP requirement, Out of Specification, corrective action, 483
5.
 
The Veterinary Drug Approval Process and FDA Regulatory Oversight
ID
852514
Dates
15 dec 2016 - 16 dec 2016
Lieu
Kansas City, États-Unis
Résumé
The U.S. Food and Drug Administration’s Center for Veterinary Medicine or CVM is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA veterinary drug approval process, center for veterinary medicine, new animal drug application, investigational new animal drug (INAD) file, animal disease diagnostic devices, veterinary medicine regulations, veterinary drug user fees
6.
 
The Benefit/Risk Ratio: Pharmacovigilance, Medical And Regulatory Converge
ID
852535
Dates
15 dec 2016 - 16 dec 2016
Lieu
Zurich, États-Unis
Résumé
In this two day workshop conference we will review requirements of EMA and EU regulatory authorities. The course will focus on the laws and regulations for Pharmacovigilance during Pre-marketing and Post-marketing (EMA, GVP, ICH). Attendees will get different points of views on Regulatory, Scientific, Ethical, Marketing and understanding about the role of GVP (Good Vigilance Practice). You will learn to design complete strategy for PSUR/PBRER.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Pharmacovigilance (PV) Training, learn GVP (Good Vigilance Practice),
7.
 
Effective Design, Validation and Routine Maintenance of Pharmaceutical Gases
ID
852534
Dates
15 dec 2016 - 16 dec 2016
Lieu
Philadelphia, États-Unis
Résumé
Pharmaceutical gases such as Compressed, Nitrogen Argon gas systems used for the production of finished pharmaceutical or other types of products may either have direct or indirect impact to the finished products. These gases are also used for other medical and non-routine processes hence understanding the design, validation, routine monitoring, data management, failure investigations, regulations and applicability of each type of gas system ensures compliance to the required regulations. A detailed technical understanding of how to perform these critical steps during the initial evaluation or re-evaluation of a new, modified or existing gas system will eliminate expensive failure or remediation issues, inability to perform validation as well as routine testing and maintenance issues which ultimately impact or delay the release of the affected product.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
pharmaceutical gas programs, ISO 8573, FDA requirements for pharma gas, microbiological testing program for pharma gas, pharmaceutical gas testing trending program, analytical gas testing, gas testing trend reports
8.
 
Studies to Support Temperature Excursions and Shipping of Pharmaceutical Products
ID
855354
Date de début
22 dec 2016
Lieu
Palo Alto - online, États-Unis
Résumé
Upon completion of this training program, attendees will learn key factors that would affect the shipping and distribution of drug products. One must understand the product stability profile, typical environmental conditions for storage and anticipating environmental extremes for distribution. These data will be necessary to design shipping conditions in order to maintain quality of the drug product through expiry.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Temperature excursions for pharmaceutical products, pharmaceutical distribution supply chain, temperature cycling studies, shipping of drug products
9.
 
BTS — Biotech Showcase™ 2017
ID
844934
Dates
09 jan 2017 - 11 jan 2017
Lieu
San Francisco, États-Unis
Résumé
Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.The 2016 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its ninth year, Biotech Showcase 2017 is expected to feature presentations by close to 350 public and private companies and attract more than 2,600 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus two-day events Digital Medicine Showcase and Medtech Showcase.
Contact
Camille Del Carmen;     Tél.: [+1 760 930 0500];     Email.: cdelcarmen@ebdgroup.com
Sujets
Biotechnology Life Science Molecular Diagnostic Personalized Medicine Pharmaceutical Specialty Pharma
Sujets apparentés
10.
 
CGT World — Cell & Gene Therapy World
ID
844986
Dates
18 jan 2017 - 20 jan 2017
Lieu
Miami, États-Unis
Contact
Carina Hunter;     Tél.: [+44(0)2073847897];     Email.: team@phacilitate.co.uk
Sujets
cell therapy, gene therapy, clinical trials, regulatory, cord blood, bioprocessing, r&d, strategic
11.
 
Immuno World 2017 — Immunotherapy World 2017
ID
844952
Dates
18 jan 2017 - 20 jan 2017
Lieu
Miami, États-Unis
Résumé
After years of posting impressive clinical results and pushing analyst projections to greater and greater heights, immuno-oncology has solidified its status as the most exciting development in cancer treatment for a long time. Now that checkpoint inhibitors have uncloaked cancer cells, drug developers are investigating dozens of immune drug cocktails (everything from CAR-T to antibodies, vaccines and other cellular therapies) to find well-tolerated treatments which could become the first-in-line to fight cancer in patients.
Contact
Carina Hunter;     Tél.: [+44(0)2073847897];     Email.: team@phacilitate.co.uk
Sujets
immuno, immunotherapy, oncology, R&D, regulatory, supply chain, logistics, lab sessions,
Sujets apparentés
12.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830073
Dates
22 jan 2017 - 26 jan 2017
Lieu
Snowbird, Utah, États-Unis
Résumé
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Contact
Attendee Services;     Tél.: [970-262-1230 or 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
Cancer, drug discovery, immunology
13.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
852566
Dates
24 jan 2017 - 25 jan 2017
Lieu
San Francisco, États-Unis
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance, custom device promotion, fda compliance seminar
14.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
855375
Dates
26 jan 2017 - 27 jan 2017
Lieu
Orlando, États-Unis
Résumé
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9
15.
 
Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
ID
855363
Dates
26 jan 2017 - 27 jan 2017
Lieu
San Francisco, États-Unis
Résumé
This two-day comprehensive Course on Latin America Regulatory compliance requirements will cover topics ranging from pre-clinical and clinical requirements through product registration, amendments and renewals across Pharmaceuticals, Biologics, Medical Devices and Combination Products. The Course will address the structure of the regulatory agencies in Latin America and discuss local cultural nuances to help you be successful in working with the regulators.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Latin America regulations, Latin America life sciences regulations, Latam life sciences regulatory requirements, Latin America pharmaceutical regulations, Latin America medical device regulations, Latin America biologics regulations
16.
 
Supplier and Contractor Qualification and Control for Life Science Industry
ID
855417
Dates
26 jan 2017 - 27 jan 2017
Lieu
Tampa, États-Unis
Résumé
This two-day course focuses on the processes associated with the acquisition of products, materials and services that fuel and support the organization’s product manufacturing and marketing. These cross-functional processes are complex and result in conflicting objectives between decision-makers. Management is responsible for organizing and providing resources and the more they understand, the more effectively they can manage. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Supplier control program, contractor qualification, Part 211, subpart e-control, drug product containers, ICH Q7A, section VII, materials management part 820
17.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
855438
Dates
31 jan 2017 - 01 fév 2017
Lieu
Orlando, États-Unis
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document, HVAC, USP, EP and JP
18.
 
9ITIM — 9th Immunotherapeutics & Immunomonitoring Conference
ID
854204
Dates
06 fév 2017 - 07 fév 2017
Lieu
San Diego, États-Unis
Résumé
GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Immunotherapy, Immune therapeutics. Immunotherapeutics, Immunomonitoring, Immunodiagnostics
19.
 
7th Ubiquitin Research & Drug Discovery Conference
ID
855602
Dates
08 fév 2017 - 09 fév 2017
Lieu
San Diego, États-Unis
Résumé
We are pleased to invite you to GTCbio's 7th Ubiquitin Research & Drug Discovery Conference, which will take place February 8-9, 2017 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered. Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
20.
 
3rd Protease Inhibitors in Drug Discovery Conference
ID
855601
Dates
08 fév 2017 - 09 fév 2017
Lieu
San Diego, États-Unis
Résumé
We are pleased to announce the 3rd Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio on February 8-9, 2017 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, drug design of protease inhibitors, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
21.
 
11th ANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
ID
842960
Dates
12 fév 2017 - 14 fév 2017
Lieu
San Diego, Californie, États-Unis
Résumé
This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
Contact
Sara Classen;     Tél.: [Tel: +1.212.901.8009];     Email.: sclassen@alzdiscovery.org
Sujets
Neurodegeneration, Drug discovery, CNS, Alzheimer’s Disease
22.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811250
Dates
20 fév 2017 - 22 fév 2017
Lieu
Baltimore, États-Unis
Résumé
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Tél.: [1-302-231-6959];     Email.: Vaccines@madrige.com
Sujets
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Sujets apparentés
23.
 
Frontiers in Cancer Immunotherapy
ID
824414
Dates
27 fév 2017 - 28 fév 2017
Lieu
New York, NY, États-Unis
Résumé
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Sujets
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
24.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825311
Dates
05 mar 2017 - 09 mar 2017
Lieu
Breckenridge, Colorado, États-Unis
Résumé
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
25.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825180
Dates
19 mar 2017 - 22 mar 2017
Lieu
Tahoe City, California, États-Unis
Résumé
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Sujets apparentés
26.
 
8th Annual Biotherapeutics Analytical Summit
ID
829783
Dates
20 mar 2017 - 23 mar 2017
Lieu
Bethesda, États-Unis
Résumé
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Tél.: [781-972-5400];     Email.: chi@healthtech.com
27.
 
Keystone Symposia - HIV Vaccines
ID
825192
Dates
26 mar 2017 - 30 mar 2017
Lieu
Steamboat Springs, Colorado, États-Unis
Résumé
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Sujets apparentés
28.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825386
Dates
01 mai 2017 - 04 mai 2017
Lieu
Estes Park, Colorado, États-Unis
Résumé
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Sujets apparentés
29.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854261
Dates
09 mai 2017 - 11 mai 2017
Lieu
Falls Church, VA, États-Unis
Résumé
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Contact
Emma Nweton;     Tél.: [+44 (0) 1372 802016];     Email.: enewton@smithers.com
Sujets
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging

États-Unis: liste de tous les évènements/conférences.

Pre-Filled Syringes Europe
RNA Therapeutics conference
Superbugs & Superdrugs Conference

Bon à savoir...

Vous pouvez insérer un encadré afin de diffuser vos évènements et services dans cet espace.

Dernière mise à jour: 08 Décembre 2016